These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8556394)

  • 81. Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope.
    Achour A; Picard O; Mbika JP; Willer A; Snart R; Bizzini B; Carelli C; Burny A; Zagury D
    Vaccine; 1993; 11(7):609-701. PubMed ID: 7688170
    [TBL] [Abstract][Full Text] [Related]  

  • 82. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.
    Lekutis C; Shiver JW; Liu MA; Letvin NL
    J Immunol; 1997 May; 158(9):4471-7. PubMed ID: 9127013
    [TBL] [Abstract][Full Text] [Related]  

  • 83. HIV-1 gp120/V3-derived epitopes promote activation-induced cell death to superantigen-stimulated CD4+/CD45RO+ T cells.
    Porichis F; Vlata Z; Hatzidakis G; Spandidos DA; Krambovitis E
    Immunol Lett; 2007 Jan; 108(1):97-102. PubMed ID: 17141881
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function.
    Lekutis C; Letvin NL
    J Virol; 1998 Jul; 72(7):5840-4. PubMed ID: 9621044
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope.
    Shankar P; Sprang H; Lieberman J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):111-20. PubMed ID: 9768618
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison between env-specific T-cell epitopic responses in HIV-1-uninfected adults immunized with combination of ALVAC-HIV(vCP205) plus or minus rgp160MN/LAI-2 and HIV-1-infected adults.
    Ratto-Kim S; Loomis-Price LD; Aronson N; Grimes J; Hill C; Williams C; El Habib R; Birx DL; Kim JH
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):9-17. PubMed ID: 12514409
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates.
    Rubinstein A; Mizrachi Y; Pettoello-Mantovani M; Lenz J; Liu GQ; Rubinstein Y; Goldstein H; Yust I; Burke M; Vardinon N; Spirer Z; Cryz SJ
    J Acquir Immune Defic Syndr; 1999 Dec; 22(5):467-76. PubMed ID: 10961608
    [TBL] [Abstract][Full Text] [Related]  

  • 88. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development.
    Gatei MH; Good MF; Daniel RC; Lavin MF
    J Virol; 1993 Apr; 67(4):1796-802. PubMed ID: 7680386
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission.
    Halsey NA; Markham R; Wahren B; Boulos R; Rossi P; Wigzell H
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):153-7. PubMed ID: 1732507
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein.
    Culmann B; Gomard E; Kiény MP; Guy B; Dreyfus F; Saimot AG; Sereni D; Sicard D; Lévy JP
    J Immunol; 1991 Mar; 146(5):1560-5. PubMed ID: 1704397
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles.
    Layton GT; Harris SJ; Gearing AJ; Hill-Perkins M; Cole JS; Griffiths JC; Burns NR; Kingsman AJ; Adams SE
    J Immunol; 1993 Jul; 151(2):1097-107. PubMed ID: 8335892
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection.
    Musich T; Peters PJ; Duenas-Decamp MJ; Gonzalez-Perez MP; Robinson J; Zolla-Pazner S; Ball JK; Luzuriaga K; Clapham PR
    J Virol; 2011 Mar; 85(5):2397-405. PubMed ID: 21159865
    [TBL] [Abstract][Full Text] [Related]  

  • 93. HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responses.
    Steers NJ; Ratto-Kim S; de Souza MS; Currier JR; Kim JH; Michael NL; Alving CR; Rao M
    PLoS One; 2012; 7(8):e42579. PubMed ID: 22880042
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes.
    Li H; Xu CF; Blais S; Wan Q; Zhang HT; Landry SJ; Hioe CE
    J Immunol; 2009 May; 182(10):6369-78. PubMed ID: 19414790
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Characterization of HIV1-PAR, a macrophage-tropic strain: cell tropism, virus/cell entry and nucleotide sequence of the envelope glycoprotein.
    Schmidtmayerova H; Gayet O; Guettari N; Bolmont C; Hirsch I; Chermann JC
    Res Virol; 1993; 144(1):21-6. PubMed ID: 8446773
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Lymphoproliferative response to synthetic V3 loop P18 peptide and HIV-1 envelope glycoprotein among individuals immunized with gp160 candidate vaccines.
    Moukrim Z; Cho YY; Mbika JP; Achour A
    Biomed Pharmacother; 1996; 50(10):494-9. PubMed ID: 9091063
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Handling of retroviral antigens by human antigen-presenting cells.
    Fenoglio D; Li Pira G; Saverino D; Ferraris A; Lancia F; Megiovanni A; Oppezzi L; Piatti G; Buffa F; Valle MT; Kunkl A; Manca F
    Res Virol; 1996; 147(2-3):97-101. PubMed ID: 8901427
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Antigenicity of linear and cyclic peptides mimicking the disulfide loops in HIV-2 envelope glycoprotein: synthesis, reoxidation and purification.
    Belhadj Jrad B; Bahraoui E
    J Pept Res; 1998 May; 51(5):370-85. PubMed ID: 9606017
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Identification of T-cell epitopes on E2 protein of rubella virus, as recognized by human T-cell lines and clones.
    Ou D; Chong P; Choi Y; McVeigh P; Jefferies WA; Koloitis G; Tingle AJ; Gillam S
    J Virol; 1992 Nov; 66(11):6788-93. PubMed ID: 1383570
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection.
    Lorès P; Boucher V; Mackay C; Pla M; Von Boehmer H; Jami J; Barré-Sinoussi F; Weill JC
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2063-71. PubMed ID: 1493054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.